Brookfield Corp’s Abiomed Inc ABMD Stock Holding History

Brookfield Corp’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,537	Closed	-$1.61M	–	783
2022 Q3	$1.61M	Buy	6,537 +2,845	+77%	+$768K	0.01%	489
2022 Q2	$914K	Buy	+3,692	New	+$996K	﹤0.01%	514
2021 Q2	–	Sell	-2,031	Closed	-$647K	–	674
2021 Q1	$647K	Buy	+2,031	New	+$650K	﹤0.01%	400

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Brookfield Corp's ABMD Position: Q4 2022 in Review

Brookfield Corp sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 6,537 shares — an estimated $1.61M sold.

Brookfield Corp first reported a position in ABMD in Q1 2021 and held it in 3 quarters. The position peaked at $1.61M in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Brookfield Corp reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Brookfield Corp sold 6,537 Abiomed Inc shares in Q4 2022, an estimated $1.61M.
Brookfield Corp first reported a position in Abiomed Inc in Q1 2021 and held it in 3 quarters.
Brookfield Corp's Abiomed Inc position peaked at $1.61M in Q3 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Brookfield Corp's 13F filing for Q4 2022, filed 14 Feb 2023.